Feminine Pain Relief

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with menstrual cramps, lower pelvic pain, backache, leg cramps, sprains, and strains.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Adults and children 12 years of age and older are instructed to apply the patch to the affected area no more than two times daily. For children under 12 years of age, it is recommended to consult a doctor prior to use.

To apply the patch, first open the pouch and remove the patch. Peel off the protective film, ensuring that the sticky side is exposed. Prior to application, the skin at the site should be thoroughly dried to ensure optimal adhesion of the patch. The patch should then be applied directly to the affected area.

Contraindications

Use of this product is contraindicated in the following situations:

Application on wounds or damaged skin is prohibited due to the potential for irritation and adverse reactions. The use of a heating pad in conjunction with this product is also contraindicated, as it may increase the risk of burns or skin damage.

Contact with eyes, mucous membranes, and rashes must be avoided to prevent irritation and potential injury. Additionally, tight bandaging is not recommended, as it may impede circulation and lead to complications.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only, this product must be utilized strictly as directed to ensure safety and efficacy.

Contraindications This product should not be applied to wounds or damaged skin, nor should it be used in conjunction with a heating pad, as these practices may lead to adverse effects.

Pre-Use Consultation Healthcare professionals should advise patients to consult a physician prior to use if there is any redness present over the affected area.

Usage Guidelines While using this product, it is imperative to avoid contact with the eyes, mucous membranes, and any rashes. Additionally, patients should refrain from applying tight bandages over the treated area to prevent complications.

Monitoring and Discontinuation Patients are instructed to discontinue use and seek medical advice if the condition worsens, if symptoms persist beyond 7 days, or if symptoms resolve only to recur within a few days. Furthermore, any abnormal skin irritation following application warrants immediate consultation with a healthcare provider.

Pediatric Safety This product should be kept out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware of several important safety considerations. It is advised to stop use and consult a healthcare professional if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Additionally, patients should seek medical advice if they experience abnormal skin irritation following usage.

Before using this product, patients should inform their healthcare provider if they have redness over the affected area. While using the product, it is crucial to avoid contact with the eyes, mucous membranes, and rashes. Patients are also advised not to bandage the area tightly and to refrain from using the product on wounds or damaged skin. The use of a heating pad in conjunction with this product is not recommended.

This product is intended for external use only and should be used strictly as directed. It is important to keep the product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Feminine Pain Relief (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may apply the medication to the affected area no more than twice daily. For children under 12 years of age, it is advised to consult a doctor prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

The product has not been evaluated for safety in pregnancy. Therefore, it is contraindicated for use in pregnant patients or those planning to become pregnant without prior consultation with a healthcare provider. There is insufficient data available to determine the risk to the fetus associated with the use of this product during pregnancy.

Healthcare professionals should advise pregnant patients to use this product only if clearly needed and after a thorough discussion of the potential risks and benefits with their healthcare provider. No specific dosage modifications are recommended for pregnant individuals.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and the safety of this product during lactation has not been established. Caution is advised when using this product while breastfeeding.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data may impact the drug's efficacy and safety profile in this population. Regular monitoring of renal function is advisable to ensure appropriate management of therapy in these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management strategies.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any overdosage incidents to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to inform patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental exposure.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place, avoiding direct sunlight to maintain its integrity. Additionally, the product must be protected from excessive moisture to ensure optimal quality and efficacy. Proper handling and storage conditions are crucial for preserving the product's effectiveness.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of no more than twice daily for adults and children aged 12 years and older. For children under 12 years of age, it is advised to consult a doctor prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Feminine Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)